Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%
NCT ID: NCT00893100
Last Updated: 2009-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
1 participants
INTERVENTIONAL
2007-10-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Analgesia Post-Haemorrhoidectomy
NCT04276298
Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure
NCT04887818
Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study
NCT06307106
Diltiazem Hydrochloride Cream for Anal Fissure
NCT01217515
Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures
NCT01690221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diltiazem
Diltiazem
2%,3 times daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diltiazem
2%,3 times daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tehran University of Medical Sciences
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Farshad Jalili, Resident
Role: PRINCIPAL_INVESTIGATOR
Sina Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sina General Hospital
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.